Xortx Therapeutics logo

Xortx Therapeutics share price today

(XRTX)

Xortx Therapeutics share price is $1.33 & ₹114.13 as on 7 Jan 2025, 2.30 'hrs' IST

$1.33

0.13

(10.83%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Xortx Therapeutics share price in Dollar and Rupees. Guide to invest in Xortx Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xortx Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Xortx Therapeutics share price movements

  • Today's Low: $1.15
    Today's High: $1.39

    Day's Volatility :17.07%

  • 52 Weeks Low: $1.06
    52 Weeks High: $7.00

    52 Weeks Volatility :84.86%

Xortx Therapeutics Returns

PeriodXortx Therapeutics IncIndex (Russel 2000)
3 Months
-33.33%
0.0%
6 Months
-30.18%
0.0%
1 Year
-53.31%
0.0%
3 Years
-36.84%
-19.8%

Xortx Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.2
Open
$1.33
Today's High
$1.3867
Today's Low
$1.15
Market Capitalization
$4.3M
Today's Volume
$263.4K
52 Week High
$7.0
52 Week Low
$1.06
Revenue TTM
$0.0
EBITDA
$-3.3M
Earnings Per Share (EPS)
$0.12
PE Ratio
10.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.36%

How to invest in Xortx Therapeutics from India?

It is very easy for Indian residents to invest directly in Xortx Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xortx Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xortx Therapeutics or XRTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xortx Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xortx Therapeutics shares which would translate to 0.645 fractional shares of Xortx Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xortx Therapeutics, in just a few clicks!

Returns in Xortx Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xortx Therapeutics investment value today

Current value as on today

₹54,974

Returns

₹45,026

(-45.03%)

Returns from Xortx Therapeutics Stock

₹48,249 (-48.25%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Xortx Therapeutics

88%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Xortx Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 88% more investors are searching Xortx Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Xortx Therapeutics

  • UBS Group AG

    0.58%

  • Advisor Group Holdings, Inc.

    0.04%

  • Royal Bank of Canada

    0.02%

  • Hartland & Co

    0.01%

  • JPMorgan Chase & Co

    0.01%

Analyst Recommendation on Xortx Therapeutics

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Xortx Therapeutics(by analysts ranked 0 to 5 stars)

Based on 5 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
4
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xortx Therapeutics

What analysts predicted

Upside of 815.04%

Current:

$1.33

Target:

$12.17

Insights on Xortx Therapeutics

  • Price Movement

    In the last 1 month, XRTX stock has moved up by 4.3%
  • XRTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 80.2%
  • XRTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 95.2%

Xortx Therapeutics Technicals Summary

Sell

Neutral

Buy

Xortx Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Xortx Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xortx Therapeutics Inc
1.51%
-30.18%
-53.31%
-36.84%
-61.78%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xortx Therapeutics Inc
10.5
10.5
NA
0.0
-0.29
-0.33
NA
2.32
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xortx Therapeutics Inc
Buy
$4.3M
-61.78%
10.5
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Xortx Therapeutics

xortx therapeutics inc., a bio-pharmaceutical company, focuses on the development and commercialization of therapies to treat progressive kidney diseases worldwide. it has two lead programs, including treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease. the company focuses on developing therapies for health consequences that includes pre-diabetes, diabetes, and cardiovascular disease. in addition, it develops uric acid lowering agents to treat diabetic nephropathy, hypertension, insulin resistance, metabolic syndrome, and diabetes; and xanthine oxidase inhibitors. the company has a strategic alliance with teijin pharma limited to develop tmx-049, a xanthine oxidoreductase; and a partnership with the icahn school of medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with covid-19. xortx therapeutics inc. is headquartered in calgary, canada.
Organization
Xortx Therapeutics
Employees
2
CEO
Dr. Allen Warren Davidoff Ph.D.
Industry
Miscellaneous

Management People of Xortx Therapeutics

NameTitle
Dr. Allen Warren Davidoff Ph.D.
Founder, CEO, President & Director
Mr. James Neville Fairbairn C.A., C.P.A., ICD.D
Chief Financial Officer
Dr. Stephen Haworth M.D., MRCP
Chief Medical Officer
Dr. Stacy Evans M.B.A., M.D.
Chief Business Officer
Nick Rigopoulos
Director of Communications
Dr. David Sans M.B.A., Ph.D.
Director of Corporate Development
Dr. David MacDonald Ph.D.
Consultant of Clinical Operations
Ms. Charlotte May
Corporate Secretary

Important FAQs about investing in Xortx Therapeutics from India :

What is Xortx Therapeutics share price today?

Xortx Therapeutics share price today stands at $1.33, Open: $1.33 ; Previous Close: $1.20 ; High: $1.39 ; Low: $1.15 ; 52 Week High: $7.00 ; 52 Week Low: $1.06. The stock opens at $1.33, after a previous close of $1.20. The stock reached a daily high of $1.39 and a low of $1.15, with a 52-week high of $7.00 and a 52-week low of $1.06.

Can Indians buy Xortx Therapeutics shares?

Yes, Indians can invest in the Xortx Therapeutics (XRTX) from India.

With INDmoney, you can buy Xortx Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xortx Therapeutics at zero transaction cost.

How can I buy Xortx Therapeutics shares from India?

It is very easy to buy Xortx Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xortx Therapeutics be purchased?

Yes, you can buy fractional shares of Xortx Therapeutics with INDmoney app.

What are the documents required to start investing in Xortx Therapeutics stocks?

To start investing in Xortx Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xortx Therapeutics

Today’s highest price of Xortx Therapeutics (XRTX) is $1.39.

Today’s lowest price of Xortx Therapeutics (XRTX) is $1.15.

What is today's market capitalisation of Xortx Therapeutics

Today's market capitalisation of Xortx Therapeutics XRTX is 4.3M

What is the 52 Week High and Low Range of Xortx Therapeutics

  • 52 Week High

    $7.00

  • 52 Week Low

    $1.06

What are the historical returns of Xortx Therapeutics?

  • 1 Month Returns

    1.51%

  • 3 Months Returns

    -30.18%

  • 1 Year Returns

    -53.31%

  • 5 Years Returns

    -61.78%

Who is the Chief Executive Officer (CEO) of Xortx Therapeutics

Dr. Allen Warren Davidoff Ph.D. is the current Chief Executive Officer (CEO) of Xortx Therapeutics.